Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Artivion
Acquired Company
Endospan
Kennesaw
Tel Aviv DistrictManufacturingBiotechnologyHealthcareHealth CareMedicalMedical DeviceBiotechnologyHealth CareMedical DeviceDescription
Artivion is set to acquire full ownership of Endospan for approximately $135 million, with potential additional payments of up to $200 million. This acquisition follows FDA approval of Endospan’s Nexus system for aortic arch treatments. The transaction will be completed in cash and is subject to customary closing conditions.
Fundz sees it the moment Artivion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Endospan?
Endospan was acquired by Artivion, based in Kennesaw. The deal was reported on May 18, 2026. Headquartered in suburban Atlanta, Georgia, Artivion, Inc. Artivion is publicly traded (AORT) and operates in Manufacturing.
When did Artivion acquire Endospan?
Artivion's acquisition of Endospan was reported on May 18, 2026. Artivion is set to acquire full ownership of Endospan for approximately $135 million, with potential additional payments of up to $200 million. This acquisition follows FDA approval of Endospan’s Nexus system for aortic arch treatments. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Endospan do?
Endospan is a pioneer in endovascular solutions for aortic arch disease, specializing in the repair of aneurysms and dissections. It is privately held, operating in Biotechnology, and is based in Tel Aviv District.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.